SciHub
文献互助
期刊查询
2024影响因子
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
joyce930728
Lv2
120 积分
2023-06-19 加入
最近求助
最近应助
互助留言
The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment
9天前
已完结
Outcomes for Patients with Late-Stage Mutant-IDH2 (m IDH2) Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Treated with Enasidenib Vs Other Lower-Intensity Therapies in the Randomized, Phase 3 IDHentify Trial
14天前
已关闭
Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study
15天前
已完结
AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients
22天前
已完结
“Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward?
28天前
已完结
Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England: An Analysis From the National Cancer Registration and Analysis Service
1个月前
已关闭
Pooled Clinical Safety Analysis of CPX-351 Versus Conventional Chemotherapy in Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia
1个月前
已关闭
Advances in acute myeloid leukemia
1个月前
已完结
Genomic Correlates of Outcome in a Randomised Comparison of CPX-351 and FLAG-Ida in High-Risk Acute Myeloid Leukaemia and Myelodysplastic Syndrome: Results from the UK NCRI AML19 Trial
1个月前
已关闭
Comparing Outcomes between Liposomal Daunorubicin/Cytarabine (CPX-351) and HMA+Venetoclax As Frontline Therapy in Acute Myeloid Leukemia
1个月前
已完结
没有进行任何应助
速度真快
15天前
点赞
22天前
帮大忙了
27天前
已找到文献【积分已退回】
1个月前
已找到文献【积分已退回】
1个月前
标题错误,此文章中未包含求助内容
1个月前
帮大忙了
1个月前
帮大忙了
1个月前
速度真快
1个月前
帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论